These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1648215)

  • 1. Antiplatelet effect of 2-(diethylamino)-7-hydroxychromone.
    Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M; Balbi A
    Pharmacol Res; 1991 Feb; 23(2):139-48. PubMed ID: 1648215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
    Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M
    Cell Biochem Funct; 1991 Apr; 9(2):79-85. PubMed ID: 1718622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
    Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
    Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of milrinone on thromboxane A2 synthesis, cAMP phosphodiesterase and 45Ca2+ uptake by human platelets.
    Jeremy JY; Gill J; Mikhailidis D
    Eur J Pharmacol; 1993 Mar; 245(1):67-73. PubMed ID: 7682964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
    Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
    Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
    Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
    Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
    Matsumoto Y; Marukawa K; Okumura H; Adachi T; Tani T; Kimura Y
    Thromb Res; 1999 Jul; 95(1):19-29. PubMed ID: 10403683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
    Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
    Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
    Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
    J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.